These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7033463)

  • 21. Bacterial sensitivity to minocycline (minocin) of clinical isolations.
    Wamola IA; Slack RC
    East Afr Med J; 1977 Nov; 54(11):658-60. PubMed ID: 95945
    [No Abstract]   [Full Text] [Related]  

  • 22. Susceptibility of Acinetobacter calcoaceticus var. anitratus (Herellea vaginicola) to minocycline.
    Montgomerie JZ; Pickett MJ; Yoshimori RN; Chow AW; Guze LB
    Antimicrob Agents Chemother; 1976 Jul; 10(1):102-5. PubMed ID: 791084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of antibiotics on the synthesis of protein and nucleic acids in intact cells of Escherichia coli carrying R-factors].
    Korotiaev AI; Orlov VG; Astapov AA
    Antibiotiki; 1971 Sep; 16(9):797-802. PubMed ID: 4945156
    [No Abstract]   [Full Text] [Related]  

  • 24. [Inhibition of bacterial and mammalian collagenolytic activities by tetracyclines].
    Maehara R; Hinode D; Terai H; Sato M; Nakamura R; Matsuda N; Tanaka T; Sugihara K
    Nihon Shishubyo Gakkai Kaishi; 1988 Mar; 30(1):182-90. PubMed ID: 3254384
    [No Abstract]   [Full Text] [Related]  

  • 25. [Action of tetracycline on protein and nucleic acid biosyntheses in Escherichia coli].
    Gurevich AI; Kiseleva OA; Kolosov MN; Shemiakin MF
    Biokhimiia; 1969; 34(2):404-8. PubMed ID: 4895710
    [No Abstract]   [Full Text] [Related]  

  • 26. Activity of minocycline and tetracycline against respiratory pathogens related to blood levels.
    Wood MJ; Farrell W; Kattan S; Williams JD
    J Antimicrob Chemother; 1975 Sep; 1(3):323-31. PubMed ID: 241739
    [No Abstract]   [Full Text] [Related]  

  • 27. [Doxycycline and minocycline HC1; a comparative study].
    Verwey H; Driessen OM; Michel MF
    Ned Tijdschr Geneeskd; 1977 Jan; 121(2):54-8. PubMed ID: 321980
    [No Abstract]   [Full Text] [Related]  

  • 28. [In vitro antibacterial activity of doxycycline and minocycline (author's transl)].
    Yokozawa M; Nakagawa K
    Jpn J Antibiot; 1975 Aug; 28(4):600-4. PubMed ID: 1099270
    [No Abstract]   [Full Text] [Related]  

  • 29. Detection of an inducible membrane protein associated with R-factor-mediated tetracycline resistance.
    Levy SB; McMurry L
    Biochem Biophys Res Commun; 1974 Feb; 56(4):1060-8. PubMed ID: 4596957
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines.
    Nelson ML; Park BH; Andrews JS; Georgian VA; Thomas RC; Levy SB
    J Med Chem; 1993 Feb; 36(3):370-7. PubMed ID: 8426364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
    Tuckman M; Petersen PJ; Howe AY; Orlowski M; Mullen S; Chan K; Bradford PA; Jones CH
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3205-11. PubMed ID: 17620376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of minocycline on fibroblast attachment and spreading.
    Somerman MJ; Foster RA; Vorsteg GM; Progebin K; Wynn RL
    J Periodontal Res; 1988 Mar; 23(2):154-9. PubMed ID: 2967368
    [No Abstract]   [Full Text] [Related]  

  • 33. [Bacteriological and clinical study of a new tetracycline, minocycline].
    Veyssier P; Boussougant Y; Mariel C
    Pathol Biol (Paris); 1973 Jan; 21(1):59-67. PubMed ID: 4570516
    [No Abstract]   [Full Text] [Related]  

  • 34. Biosynthesis and turnover of outer-membrane proteins in Escherichia coli ML308-225.
    Allen RJ; Scott GK
    Biochem J; 1979 Aug; 182(2):407-12. PubMed ID: 389236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Action of tetracycline and sodium deoxycholate combinations on protein and nucleic acid synthesis in the cells of the NAG vibrio, Staphylococcus aureus and Escherichia coli].
    Belizhenko VD
    Antibiotiki; 1979 Jan; 24(1):42-5. PubMed ID: 371536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consequences of inhibition of Escherichia coli by tetracycline antibiotics.
    Holmes IA; Wild DG
    Nature; 1966 Jun; 210(5040):1047-8. PubMed ID: 4958199
    [No Abstract]   [Full Text] [Related]  

  • 37. Phenotypic characterization of R-factor tetracycline resistance determinants.
    Foster TJ; Walsh A
    Genet Res; 1974 Dec; 24(3):333-43. PubMed ID: 4618215
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of tetracycline and minocyclie transport in Escherichia Coli.
    Del Bene VE; Rogers M
    Antimicrob Agents Chemother; 1975 Jun; 7(6):801-6. PubMed ID: 1098571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome.
    Rasmussen B; Noller HF; Daubresse G; Oliva B; Misulovin Z; Rothstein DM; Ellestad GA; Gluzman Y; Tally FP; Chopra I
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2306-11. PubMed ID: 1725100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Activity in vitro and pharmacokinetics of minocycline (author's transl)].
    Simon C; Malerczyk V; Preuss I; Schmidt K; Grahmann H
    Arzneimittelforschung; 1976 Apr; 26(4):556-60. PubMed ID: 782466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.